In this study, we predicted that downregulated MAGI2-AS3 may be involved in PCa by leading to the low expression of inflammation (SPARC) or calcium signaling pathway related genes (GJA1 and CYSLTR1). The gene discussed is MAGI2; the disease is posterior cortical atrophy.